FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT in Adult and Paediatric Patients with AML or MDS By Ogkologos - March 13, 2025 692 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the MC-FludT.14/L Trial II Source RELATED ARTICLESMORE FROM AUTHOR FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma Mortality Trends for Most Cancers Remain Favourable In the EU, Although the Absolute Number of Cancer Deaths Is Not Declining Due To Population Ageing MOST POPULAR ΚΑΡΚΙΝΟΣ ΟΡΧΕΩΝ February 10, 2019 Science Surgery: ‘Can cancers develop in the heart?’ March 30, 2021 Copanlisib Shows Promising Clinical Activity in Select Tumours with PIK3CA Mutation... February 14, 2022 Progress in Treating Liver Cancer and Biliary Tract Cancer with Immunotherapy:... January 18, 2022 Load more HOT NEWS Cancer research could revive the UK’s ailing public finances How I Navigated Being a Young Mom During Cancer: A Survivor’s... Should alcohol marketing be dropped from televised sport? Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit...
